8-Hydroxy Quinaldine

8-Hydroxy Quinaldine

SCHEMBL625310

Cc1ccc2cccc(O)c2n1.Cc1ccc2cccc(O)c2n1.Oc1ccccc1.[Al]

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.79
KMT2A Q03164 5/20 0.49
KDM4E B2RXH2 3/20 0.49
PLAU P00749 1/20 0.49
NCF1 P14598 1/20 0.49
ALOX12 P18054 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47
CYP2C19 P33261 1/20 0.47
HIF1A Q16665 1/20 0.47
HSD17B10 Q99714 1/20 0.47
RAB9A P51151 2/20 0.47
CCR1 P32246 1/20 0.47
CCR5 P51681 1/20 0.47
CD74 P04233 1/20 0.46
MIF P14174 1/20 0.46
PARP1 P09874 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
8-Hydroxy Quinaldine SCHEMBL30128554 1.00 METAP2 (0.79) METAP2KMT2AKDM4EPLAUNCF1
8-Hydroxy Quinaldine SCHEMBL8634752 1.00 METAP2 (0.79) METAP2KMT2AKDM4EPLAUNCF1
8-Hydroxy Quinaldine SCHEMBL3265166 0.98 METAP2 (0.82) METAP2KMT2AKDM4EPLAUNCF1
8-Hydroxy Quinaldine SCHEMBL4386958 0.97 METAP2 (0.79) METAP2KMT2AKDM4EPLAUNCF1
8-Hydroxy Quinaldine SCHEMBL19640292 0.97 METAP2 (0.79) METAP2KMT2AKDM4EPLAUNCF1
8-Hydroxy Quinaldine SCHEMBL19327239 0.97 METAP2 (0.79) METAP2KMT2AKDM4EPLAUNCF1
8-Hydroxy Quinaldine SCHEMBL5089361 0.91 METAP2 (0.96) METAP2KMT2AKDM4EPLAUNCF1
8-Hydroxy Quinaldine SCHEMBL30295552 0.91 METAP2 (0.96) METAP2KMT2AKDM4EPLAUNCF1
8-Hydroxy Quinaldine SCHEMBL546577 0.91 METAP2 (0.96) METAP2KMT2AKDM4EPLAUNCF1
8-Hydroxy Quinaldine SCHEMBL262742 0.91 METAP2 (0.96) METAP2KMT2AKDM4EPLAUNCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030108770-A1 Organic electroluminescent device SANYO ELECTRIC CO., LTD. (JP) 2003-06-12 US claimed
EP-4383238-A2 IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE Mitsubishi Chemical Corporation (JP) 2024-06-12 EP disclosed
EP-3719028-B1 IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING SAID COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING SAID COMPOUND, DISPLAY DEVICE AND ILLUMINATION DEVICE MITSUBISHI CHEM CORP (JP) 2024-06-12 EP disclosed
WO-2024117109-A1 COMPOSITION FOR FORMING LIGHT EMITTING LAYER OF ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR PRODUCING SAME, AND DISPLAY DEVICE 三菱ケミカル株式会社 2024-06-06 WO disclosed
WO-2024096035-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC EL DISPLAY PANEL, METHOD FOR MANUFACTURING ORGANIC EL DISPLAY PANEL, METHOD FOR DESIGNING FILM THICKNESS CONFIGURATION OF ORGANIC ELECTROLUMINESCENT ELEMENT, AND METHOD FOR DESIGNING FILM THICKNESS CONFIGURATION OF ORGANIC EL DISPLAY PANEL 三菱ケミカル株式会社 2024-05-10 WO disclosed
EP-4349814-A1 IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR PRODUCING SAME Mitsubishi Chemical Corporation (JP) 2024-04-10 EP disclosed
US-20240107870-A1 POLYMER, COMPOSITION FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC EL DISPLAY DEVICE, ORGANIC EL LIGHTING, AND MANUFACTURING METHOD FOR ORGANIC ELECTROLUMINESCENT ELEMENT MITSUBISHI CHEMICAL CORPORATION (JP) 2024-03-28 US disclosed
US-11943997-B2 Polymer, composition for organic electroluminescent element, organic electroluminescent element, organic EL display device, organic EL lighting, and manufacturing method for organic electroluminescent element MITSUBISHI CHEMICAL CORPORATION (JP) 2024-03-26 US disclosed
WO-2024048691-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC EL DISPLAY DEVICE, ORGANIC EL LIGHTING, AND METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT 三菱ケミカル株式会社 2024-03-07 WO disclosed
WO-2024048693-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC EL DISPLAY DEVICE, ORGANIC EL LIGHTING, AND METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT 三菱ケミカル株式会社 2024-03-07 WO disclosed
EP-1218345-A1 METHOD OF MAKING METAL 8-QUINOLINOLATO COMPLEXES 3M Innovative Properties Company (US) 2002-07-03 EP disclosed
US-20020055015-A1 Organic electroluminescent device MITSUBISHI CHEMICAL CORPORATION (JP) 2002-05-09 US disclosed
US-20020040143-A1 Method of making metal 8-quinolinolato complexes 3M INNOVATIVE PROPERTIES COMPANY 2002-04-04 US disclosed
US-6362339-B1 ELECTROLUMINESCENCE 3M INNOVATIVE PROPERTIES COMPANY 2002-03-26 US disclosed
WO-2001025211-A1 METHOD OF MAKING METAL 8-QUINOLINOLATO COMPLEXES 3M INNOVATIVE PROPERTIES COMPANY (US) 2001-04-12 WO disclosed
US-5989737-A Organic electroluminescent devices XEROX CORPORATION (US) 1999-11-23 US disclosed
US-5952115-A Electroluminescent devices XEROX CORPORATION (US) 1999-09-14 US disclosed
EP-0906948-A1 Electroluminescent devices Xerox Corporation (US) 1999-04-07 EP disclosed
US-5846666-A Electroluminescent devices XEROX CORPORATION (US) 1998-12-08 US disclosed
EP-0862353-A2 Electroluminescent devices XEROX CORPORATION (US) 1998-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020040143-A1 Method of making metal 8-quinolinolato complexes COQ8A, SDHA, LDHA METAP2 4351/4885KMT2A 442/4885KDM4E 2278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.